Sequencing and expression analyses of the synaptic lipid raft adapter gene PAG1 in schizophrenia

Journal of Neural Transmission

Volumn 122, Issue 3, 2015, Pages 477-485

  Balan, Shabeesh ^a   Iwayama, Yoshimi ^a   Yamada, Kazuo ^a   Toyota, Tomoko ^a   Ohnishi, Tetsuo ^a   Toyoshima, Manabu ^a   Shimamoto, Chie ^a,b   Ide, Masayuki ^c   Iwata, Yasuhide ^d   Suzuki, Katsuaki ^d   Kikuchi, Mitsuru ^e   Hashimoto, Tasuku ^f   Kanahara, Nobuhisa ^f   Yoshikawa, Takeo ^a   Maekawa, Motoko ^a  

^a RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^b OCHANOMIZU UNIVERSITY   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^f CHIBA UNIVERSITY   (Japan)

Author keywords

Lipid raft; PAG1; Rare variant; Schizophrenia

Indexed keywords

MEMBRANE PROTEIN; MESSENGER RNA; PAG1 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ADULT; AGED; BRAIN; CASE CONTROL STUDY; COHORT ANALYSIS; EXON; FEMALE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; HAPLOTYPE; HUMAN; JAPAN; MALE; METABOLISM; MIDDLE AGED; MISSENSE MUTATION; PATHOLOGY; SCHIZOPHRENIA;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; BRAIN; CASE-CONTROL STUDIES; COHORT STUDIES; EXONS; FEMALE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; JAPAN; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION, MISSENSE; RNA, MESSENGER; SCHIZOPHRENIA;

EID: 84939887640     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-014-1269-0     Document Type: Article

References (36)

1. Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE, Kang HM, Marth GT, McVean GA (2012) An integrated map of genetic variation from 1,092 human genomes. Nature 491(7422):56–65. doi:10.1038/nature11632
2. Ayalew M, Le-Niculescu H, Levey D, Jain N, Changala B, Patel S, Winiger E, Breier A, Shekhar A, Amdur R, Koller D, Nurnberger J, Corvin A, Geyer M, Tsuang M, Salomon D, Schork N, Fanous A, O’Donovan M, Niculescu A (2012) Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction. Mol Psychiatry 17(9):887–905. doi:10.1038/mp.2012.37
3. Balan S, Iwayama Y, Toyota T, Toyoshima M, Maekawa M, Yoshikawa T (2014) 22q11. 2 deletion carriers and schizophrenia-associated novel variants. Br J Psychiatry. doi:10.1192/bjp.bp.113.138420
4. Bayés À, van de Lagemaat LN, Collins MO, Croning MD, Whittle IR, Choudhary JS, Grant SG (2010) Characterization of the proteome, diseases and evolution of the human postsynaptic density. Nat Neurosci 14(1):19–21. doi:10.1038/nn.2719
5. Devlin B, Roeder K (2004) Genomic control for association studies. Biometrics 55(4):997–1004. doi:10.1111/j.0006-341X.1999.00997.x
6. Dobenecker M-W, Schmedt C, Okada M, Tarakhovsky A (2005) The ubiquitously expressed Csk adaptor protein Cbp is dispensable for embryogenesis and T-cell development and function. Mol Cell Biol 25(23):10533–10542. doi:10.1128/MCB.25.23.10533-10542.2005
7. Faludi G, Mirnics K (2011) Synaptic changes in the brain of subjects with schizophrenia. Int J Dev Neurosci 29(3):305–309. doi:10.1016/j.ijdevneu.2011.02.013
8. Foster LJ, de Hoog CL, Mann M (2003) Unbiased quantitative proteomics of lipid rafts reveals high specificity for signaling factors. Proc Natl Acad Sci 100(10):5813–5818. doi:10.1073/pnas.0631608100
9. Fromer M, Pocklington AJ, Kavanagh DH, Williams HJ, Dwyer S, Gormley P, Georgieva L, Rees E, Palta P, Ruderfer DM, Carrera N, Humphreys I, Johnson JS, Roussos P, Barker DD, Banks E, Milanova V, Grant SG, Hannon E, Rose SA, Chambert K, Mahajan M, Scolnick EM, Moran JL, Kirov G, Palotie A, McCarroll SA, Holmans P, Sklar P, Owen MJ, Purcell SM, O’Donovan MC (2014) De novo mutations in schizophrenia implicate synaptic networks. Nature 506(7487):179–184. doi:10.1038/nature12929
10. Grant SG (2012) Synaptopathies: diseases of the synaptome. Curr Opin Neurobiol 22(3):522–529. doi:10.1016/j.conb.2012.02.002
11. Groveman BR, Feng S, Fang XQ, Pflueger M, Lin SX, Bienkiewicz EA, Yu X (2012) The regulation of N-methyl-d-aspartate receptors by Src kinase. FEBS J 279(1):20–28. doi:10.1111/j.1742-4658.2011.08413.x
12. Hahn C-G, Wang H-Y, Cho D-S, Talbot K, Gur RE, Berrettini WH, Bakshi K, Kamins J, Borgmann-Winter KE, Siegel SJ, Gallop RJ, Arnold SE (2006) Altered neuregulin 1–erbB4 signaling contributes to NMDA> receptor hypofunction in schizophrenia. Nat Med 12(7):824–828. doi:10.1038/nm1418
13. Hattori E, Toyota T, Ishitsuka Y, Iwayama Y, Yamada K, Ujike H, Morita Y, Kodama M, Nakata K, Minabe Y, Nakamura K, Iwata Y, Takei N, Mori N, Naitoh H, Yamanouchi Y, Iwata N, Ozaki N, Kato T, Nishikawa T, Kashiwa A, Suzuki M, Shioe K, Shinohara M, Hirano M, Nanko S, Akahane A, Ueno M, Kaneko N, Watanabe Y, Someya T, Hashimoto K, Iyo M, Itokawa M, Arai M, Nankai M, Inada T, Yoshida S, Kunugi H, Nakamura M, Iijima Y, Okazaki Y, Higuchi T, Yoshikawa T (2009) Preliminary genome-wide association study of bipolar disorder in the Japanese population. Am J Med Genet Part B: Neuropsychiatr Genet 150(8):1110–1117. doi:10.1002/ajmg.b.30941
14. Hrdinka M, Horejsi V (2013) PAG-a multipurpose transmembrane adaptor protein. Oncogene. doi:10.1038/onc.2013.485
15. Kawabuchi M, Satomi Y, Takao T, Shimonishi Y, Nada S, Nagai K, Tarakhovsky A, Okada M (2000) Transmembrane phosphoprotein Cbp regulates the activities of Src-family tyrosine kinases. Nature 404(6781):999–1003. doi:10.1038/35010121
16. Lindquist S, Karitkina D, Langnaese K, Posevitz-Fejfar A, Schraven B, Xavier R, Seed B, Lindquist JA (2011) Phosphoprotein associated with glycosphingolipid-enriched microdomains differentially modulates Src kinase activity in brain maturation. PLoS One 6(9):e23978. doi:10.1371/journal.pone.0023978
17. Lips ES, Cornelisse LN, Toonen RF, Min JL, Hultman C, Holmans P, O’Donovan M, Purcell S, Smit A, Verhage M, Sullivan PF, Visscher P, Posthuma D (2011) Functional gene group analysis identifies synaptic gene groups as risk factor for schizophrenia. Mol Psychiatry 17(10):996–1006. doi:10.1038/mp.2011.117
18. MacArthur DG, Balasubramanian S, Frankish A, Huang N, Morris J, Walter K, Jostins L, Habegger L, Pickrell JK, Montgomery SB, Albers CA, Zhang ZD, Conrad DF, Lunter G, Zheng H, Ayub Q, DePristo MA, Banks E, Hu M, Handsaker RE, Rosenfeld JA, Fromer M, Jin M, Mu XJ, Khurana E, Ye K, Kay M, Saunders GI, Suner M-M, Hunt T, Barnes IHA, Amid C, Carvalho-Silva, Bignell AH, Snow C, Yngvadottir B, Bumpstead S, Cooper DN, Xue Y, Romero IG, Consortium GP, Wang J, Li Y, Gibbs RA, McCarroll SA, Dermitzakis ET, Pritchard JK, Barrett JC, Harrow J, Hurles ME, Gerstein MB, Tyler-Smith C (2012) A systematic survey of loss-of-function variants in human protein-coding genes. Science 335(6070):823–828. doi:10.1126/science.1215040
19. Maynard TM, Sikich L, Lieberman JA, LaMantia A-S (2001) Neural development, cell-cell signaling, and the “two-hit” hypothesis of schizophrenia. Schizophr Bull 27(3):457–476
20. Pawson T, Scott JD (1997) Signaling through scaffold, anchoring, and adaptor proteins. Science 278(5346):2075–2080. doi:10.1126/science.278.5346.2075
21. Pritchard JK, Stephens M, Donnelly P (2000) Inference of population structure using multilocus genotype data. Genetics 155(2):945–959
22. Purcell SM, Moran JL, Fromer M, Ruderfer D, Solovieff N, Roussos P, O/’Dushlaine C, Chambert K, Bergen SE, Kahler A, Duncan L, Stahl E, Genovese G, Fernandez E, Collins MO, Komiyama NH, Choudhary JS, Magnusson PKE, Banks E, Shakir K, Garimella K, Fennell T, DePristo M, Grant SGN, Haggarty SJ, Gabriel S, Scolnick EM, Lander ES, Hultman CM, Sullivan PF, McCarroll SA, Sklar P (2014) A polygenic burden of rare disruptive mutations in schizophrenia. Nature 506(7487):185–190. doi:10.1038/nature12975
23. Ripke S, O’Dushlaine C, Chambert K, Moran JL, Kahler AK, Akterin S, Bergen SE, Collins AL, Crowley JJ, Fromer M, Kim Y, Lee SH, Magnusson PKE, Sanchez N, Stahl EA, Williams S, Wray NR, Xia K, Bettella F, Borglum AD, Bulik-Sullivan BK, Cormican P, Craddock N, de Leeuw C, Durmishi N, Gill M, Golimbet V, Hamshere ML, Holmans P, Hougaard DM, Kendler KS, Lin K, Morris DW, Mors O, Mortensen PB, Neale BM, O’Neill FA, Owen MJ, Milovancevic MP, Posthuma D, Powell J, Richards AL, Riley BP, Ruderfer D, Rujescu D, Sigurdsson E, Silagadze T, Smit AB, Stefansson H, Steinberg S, Suvisaari J, Tosato S, Verhage M, Walters JT, Multicenter Genetic Studies of Schizophrenia C, Psychosis Endophenotypes International C, Wellcome Trust Case Control C, Bramon E, Corvin AP, O’Donovan MC, Stefansson K, Scolnick E, Purcell S, McCarroll SA, Sklar P, Hultman CM, Sullivan PF (2013) Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet 45(10):1150–1159. doi:10.1038/ng.2742
24. Salter MW, Kalia LV (2004) Src kinases: a hub for NMDA receptor regulation. Nat Rev Neurosci 5(4):317–328. doi:10.1038/nrn1368
25. Sebastião AM, Colino-Oliveira M, Assaife-Lopes N, Dias RA, Ribeiro JA (2012) Lipid rafts, synaptic transmission and plasticity: impact in age-related neurodegenerative diseases. Neuropharmacology. doi:10.1016/j.neuropharm.2012.06.053
26. Sekino-Suzuki N, Yuyama K, Miki T, Kaneda M, Suzuki H, Yamamoto N, Yamamoto T, Oneyama C, Okada M, Kasahara K (2013) Involvement of gangliosides in the process of Cbp/PAG phosphorylation by Lyn in developing cerebellar growth cones. J Neurochem 124(4):514–522. doi:10.1111/jnc.12040
27. Simons K, Toomre D (2000) Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 1(1):31–39. doi:10.1038/35036052
28. Stephan KE, Baldeweg T, Friston KJ (2006) Synaptic plasticity and dysconnection in schizophrenia. Biol Psychiatry 59(10):929–939. doi:10.1016/j.biopsych.2005.10.005
29. Sullivan PF (2012) Puzzling over schizophrenia: schizophrenia as a pathway disease. Nat Med 18(2):210–211. doi:10.1038/nm.2670
30. Takata A, Iwayama Y, Fukuo Y, Ikeda M, Okochi T, Maekawa M, Toyota T, Yamada K, Hattori E, Ohnishi T, Toyoshima M, Ujike H, Inada T, Kunugi H, Ozaki N, Nanko S, Nakamura K, Mori N, Kanba S, Iwata N, Kato T, Yoshikawa T (2012) A population-specific uncommon variant in GRIN3A associated with schizophrenia. Biol Psychiatry. doi:10.1016/j.biopsych.2012.10.024
31. Toyosima M, Maekawa M, Toyota T, Iwayama Y, Arai M, Ichikawa T, Miyashita M, Arinami T, Itokawa M, Yoshikawa T (2011) Schizophrenia with the 22q11. 2 deletion and additional genetic defects: case history. The. Br J Psychiatry 199(3):245–246. doi:10.1192/bjp.bp.111.093849
32. Xu S, Huo J, Tan JE-L, Lam K-P (2005) Cbp deficiency alters Csk localization in lipid rafts but does not affect T-cell development. Mol cell Biol 25(19):8486–8495. doi:10.1128/MCB.25.19.8486-8495.2005
33. Xu B, Roos JL, Dexheimer P, Boone B, Plummer B, Levy S, Gogos JA, Karayiorgou M (2011) Exome sequencing supports a de novo mutational paradigm for schizophrenia. Nat Genet 43(9):864–868. doi:10.1038/ng.902
34. Yamada K, Nakamura K, Minabe Y, Iwayama-Shigeno Y, Takao H, Toyota T, Hattori E, Takei N, Sekine Y, Suzuki K, Iwata Y, Miyoshi K, Honda A, Baba K, Katayama T, Tohyama M, Mori N, Yoshikawa T (2004) Association analysis of FEZ1 variants with schizophrenia in Japanese cohorts. Biol Psychiatry 56(9):683–690. doi:10.1016/j.biopsych.2004.08.015
35. Yamada K, Hattori E, Iwayama Y, Ohnishi T, Ohba H, Toyota T, Takao H, Minabe Y, Nakatani N, Higuchi T, Detera-Wadleigh SD, Yoshikawa T (2006) Distinguishable haplotype blocks in the HTR3A and HTR3B region in the japanese reveal evidence of association of HTR3B with female major depression. Biol Psychiatry 60(2):192–201. doi:10.1016/j.biopsych.2005.11.008
36. Yamaguchi-Kabata Y, Nakazono K, Takahashi A, Saito S, Hosono N, Kubo M, Nakamura Y, Kamatani N (2008) Japanese population structure, based on SNP genotypes from 7003 individuals compared to other ethnic groups: effects on population-based association studies. Am J Hum Genet 83(4):445–456. doi:10.1016/j.ajhg.2008.08.019